Martin-Immanuel Bittner

Chief Executive Officer, Redouble AI

Martin-Immanuel Bittner MD DPhil is the Co-Founder & CEO of Redouble AI, a technology company backed by Y Combinator that develops and implements enterprise AI solutions in regulated industries. Before that, he was the CEO of Arctoris, a pharma workflow automation company headquartered in Oxford which he co-founded in 2016. In terms of background, Martin is a physician-scientist, having graduated as a medical doctor from the University of Freiburg in Germany, followed by his DPhil in Oncology as a Rhodes scholar at the University of Oxford. A repeat founder in (health)tech, he has been named Innovator of the Year in Biotechnology 2020 by SBR, and has been elected as a member of the Young Academy of the German National Academy of Sciences as well as of Sigma Xi. He has extensive research experience covering both clinical trials and preclinical drug discovery and is a member of several leading cancer research organizations, including EACR, AACR, and ESTRO.